There is no fee for this activity and registration will be granted on a first-come, first-served basis. Register early and reserve your space!

To register for this Summit:
Click Here>>
or call
(866) 856-1998


Michael S. Machuzak, MD, FCCP
Medical Director
Center for Major Airway
Transplant Center
Respiratory Institute
Cleveland Clinic
Cleveland, Ohio


Andrea Arrossi, MD
Pulmonary Staff Pathologist
Anatomic Pathology
Cleveland Clinic
Cleveland, Ohio

Joseph C. Cicenia III, MD, FCCP
Respiratory Institute
Interventional Bronchoscopy
Cleveland Clinic Foundation
Cleveland, Ohio

Patrick C. Ma, MD, MS
Aerodigestive Oncology Translational Research
Assistant Professor of Molecular Medicine
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio


The American College of Chest Physicians (ACCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ACCP designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Individuals should claim only the credit commensurate with the extent of their participation in the activity.

Supported by an independent professional education grant from Pfizer, Inc.

Know someone who would be interested in receiving this information? Click here to tell them about it.

FRIDAY, JUNE 1, 2012
InterContinental Cleveland
The Founders Ballroom C, 2nd Floor
Cleveland, Ohio

The goal of the Summit is to improve the knowledge, competence, and performance of a team of interdisciplinary specialists who are currently responsible for appropriate staging, mediastinal assessment, tissue acquisition, and biomarker analysis in patients with Non-small Cell Lung Cancer (NSCLC).

7:45 AM  


8:15 AM  

Welcome and Introduction

8:30 AM   Mediastinal Staging
9:10 AM   Tumor Biomarkers and Targeted Therapy for NSCLC
9:50 AM   Mid-Morning Break
10:05 AM   Barriers to the Pathologist
10:45 AM   Specimen Collection and Assays for Molecular Targets: Challenges for an Interdisciplinary Team
11:25 AM   Breakout Sessions
Breakout #1: Interactive Bronchoscopy Simulations or Pathology Image Review
Breakout #2: Problem-based Learning (PBL) Case Discussions
12:55 PM   Lunch
1:25 PM   Breakout Sessions
2:55 PM   PBL Panel Discussion: Reports from Interdisciplinary Teams
3:15 PM   Questions and Answers and Meeting Wrap-up
3:45 PM   Adjourn

At the conclusion of this activity, you should be able to:

  • Describe the continuing emergence of tumor biomarkers and targeted therapy in the personalized care of patients with NSCLC
  • Demonstrate the knowledge and skills required to obtain an adequate tissue sample for NSCLC diagnosis and classification
  • Identify the current biomarkers utilized to categorize molecular and histologic features of NSCLC and their relevant applications for diagnosis, monitoring, and personalized care

 A Product of The France Foundation | Powered by Peer360°